COVID-19 Therapeutics: Resources for Health Care Professionals and Public Health Officials
COVID-19 therapeutics can be used to prevent or treat eligible non-hospitalized patients who have mild to moderate COVID-19 symptoms. Prevention and early treatment for eligible patients can help improve patient outcomes, reduce stress on healthcare facilities, and even save lives.
HHS/ASPR has purchased supplies of COVID-19 therapeutic products and we are working with state and territorial health departments as well as national healthcare and medical organizations and associations to get the treatments into the hands of healthcare providers quickly, with a focus on areas of the country hardest hit by the pandemic.
Featured Resources
Outpatient COVID-19 Therapeutics
Previously Available COVID-19 Therapeutic Products
The products listed below are not currently authorized in the U.S because they are not expected to be effective against the currently circulating SARS-CoV-2 variants. Providers with non-expired inventory of these products are encouraged to retain them, as they have the potential to treat future variants more effectively.
Increasing Access to COVID-19 Therapeutics
